Innate Pharma

📍 Marseille, France🗓 Founded 1999👥 220 employees💰 Last funded 2011
Biotechnology Research🌐 innate-pharma.com
Website LinkedIn
Innate Pharma S.A. is a global, clinical-stage oncology-focused biotech company dedicated to improving treatment and clinical outcomes for patients through therapeutic antibodies that harness the immune system to fight cancer. Innate Pharma’s broad pipeline of antibodies includes several potentially first-in-class clinical and preclinical candidates in cancers with high unmet medical need. Innate has been a pioneer in the understanding of natural killer cell (NK cell) biology and has expanded its expertise in the tumor microenvironment and tumor-antigens, as well as antibody engineering. This innovative approach has resulted in a diversified proprietary portfolio and major alliances with leaders in the biopharmaceutical industry including Bristol-Myers Squibb Novo Nordisk A/S, Sanofi, and a multi-products collaboration with AstraZeneca. Based in Marseille, France, Innate Pharma is listed on Euronext Paris and Nasdaq in the US.
2
Total investors
1
Early stage
0
Mid stage
0
Late stage
1999
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
France
1
Belgium
1
Frequently asked questions
Who invested in Innate Pharma?
Innate Pharma has 2 investors on record on gritt.io, including 1 early-stage backers.
When did Innate Pharma last raise funding?
The most recent investment in Innate Pharma recorded on gritt.io was in 2011.
When was Innate Pharma founded?
Innate Pharma was founded in 1999.
What industry is Innate Pharma in?
Innate Pharma operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Innate Pharma based?
Innate Pharma is headquartered in Marseille, France.